Cargando…

The Neutrophil Percentage-to-Albumin Ratio is Associated with All-Cause Mortality in Patients with Atrial Fibrillation: A Retrospective Study

OBJECTIVE: The present study aimed to evaluate the relationship between all-cause mortality and the neutrophil percentage-to-albumin ratio (NPAR) in patients with atrial fibrillation (AF). METHODS: We obtained clinical information from patients with AF from the Medical Information Mart for Intensive...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yuxuan, Lin, Zhihui, Zhu, Chenxi, Song, Dongyan, Wu, Bosen, Ji, Kangting, Li, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946812/
https://www.ncbi.nlm.nih.gov/pubmed/36844255
http://dx.doi.org/10.2147/JIR.S394536
Descripción
Sumario:OBJECTIVE: The present study aimed to evaluate the relationship between all-cause mortality and the neutrophil percentage-to-albumin ratio (NPAR) in patients with atrial fibrillation (AF). METHODS: We obtained clinical information from patients with AF from the Medical Information Mart for Intensive Care-IV version 2.0 (MIMIC-IV) database and the Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University (WMU). The clinical endpoints were all-cause death measured at 30-day, 90-day, and one-year intervals. For endpoints associated with the NPAR, logistic regression models were used to calculate odds ratios (OR) with 95% confidence intervals (CI). Receiver operating characteristic (ROC) curves and area under the curve (AUC) were developed to compare the ability of different inflammatory biomarkers to predict 90-day mortality in patients with AF. RESULTS: Higher NPAR was associated with a higher risk of 30-day (OR 2.08, 95% CI 1.58–2.75), 90-day (OR 2.07, 95% CI 1.61–2.67), and one-year mortality (OR 1.60, 95% CI 1.26–2.04) in patients with AF in 2813 patients from MIMIC-IV. The predictive performance of NPAR (AUC = 0.609) for 90-day mortality was better than that of neutrophil-to-lymphocyte ratio (NLR) (AUC = 0.565, P < 0.001), and platelet-to-lymphocyte ratio (PLR) (AUC = 0.528, P < 0.001). When NPAR and sequential organ failure assessment (SOFA) were combined, the AUC increased from 0.609 to 0.674 (P < 0.001). Higher NPAR was associated with a higher risk of 30-day mortality (OR 2.54, 95% CI 1.02–6.30) and 90-day mortality (OR 2.76, 95% CI 1.09–7.01) in 283 patients from WMU. CONCLUSION: An increased 30-day, 90-day, and one-year mortality risk among patients with AF were linked to a higher NPAR in MIMIC-IV. NPAR was thought to be a good predictor of 90-day all-cause mortality. Higher NPAR was associated with a higher risk of 30-day and 90-day mortality in WMU.